CDIX — Cardiff Lexington Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Cardiff Lexington, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-2.92	0.666	-5.43	3.03	-3.3
Depreciation
Non-Cash Items	0.949	0.111	2.81	0.144	2.52
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.999	-1.84	1.44	-4.91	-4.98
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-0.948	-1.05	-1.15	-1.72	-5.75
Capital Expenditures	—	-0.003	—	—	—
Purchase of Fixed Assets
Other Investing Cash Flow Items	0	-2.32	—	—	—
Acquisition of Business
Sale of Fixed Assets
Cash from Investing Activities	0	-2.32	—	—	—
Financing Cash Flow Items	-0.11	0	-0.004	-0.002	-0.121
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1.15	3.68	0.789	2.37	6.07
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.202	0.302	-0.362	0.648	0.321